| Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations JH Starrett, AA Guernet, ME Cuomo, KE Poels, ... Cancer research 80 (10), 2017-2030, 2020 | 63 | 2020 |
| Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer Y Inoue, A Nikolic, D Farnsworth, R Shi, FD Johnson, A Liu, M Ladanyi, ... Elife 10, e66524, 2021 | 18 | 2021 |
| Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells FD Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... Cell reports 38 (6), 2022 | 15 | 2022 |
| MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression DA Farnsworth, Y Inoue, FD Johnson, G de Rappard-Yuswack, D Lu, ... NPJ Precision Oncology 6 (1), 88, 2022 | 12 | 2022 |
| Emerging molecular dependencies of mutant EGFR-driven non-small cell lung cancer DA Farnsworth, YT Chen, G de Rappard Yuswack, WW Lockwood Cells 10 (12), 3553, 2021 | 11 | 2021 |
| MEK inhibitor resistance in lung cancer cells associated with addiction to sustained ERK suppression DA Farnsworth, Y Inoue, FD Johnson, G de Rappard-Yuswack, D Lu, ... bioRxiv, 2022.04. 29.490009, 2022 | 2 | 2022 |
| A novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1 FD Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... bioRxiv, 2021.06. 28.450088, 2021 | 1 | 2021 |
| Characterizing the secretome of EGFR mutant lung adenocarcinoma JK Luu, FD Johnson, J Jajarmi, T Sihota, R Shi, D Lu, D Farnsworth, ... Frontiers in Oncology 13, 1286821, 2024 | | 2024 |
| EP08. 02-055 Targeting Lung Adenocarcinoma Cells with a Novel Disulfide Reductase Inhibitor F Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... Journal of Thoracic Oncology 17 (9), S424, 2022 | | 2022 |
| B13 Selectively Targeting Lung Cancer with a Novel Small Molecule that Induces Lethality Through Dual Inhibition of Disulfide Reductases FD Johnson, S Jansen, A Liu, C Brandstädter, D Lu, A Nagelberg, ... Journal of Thoracic Oncology 15 (2), S31-S32, 2020 | | 2020 |
| B32 Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations JH Starrett, A Guernet, ME Cuomo, K Poels, IKA van Rosenburgh, ... Journal of Thoracic Oncology 15 (2), S36, 2020 | | 2020 |
